Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How Many Attended the Oncogenetic Consultation, When, and Who?: A Population-Based Study Among Relatives of French Patients With Cancer.

Cancer nursing·2026
Same author

Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical Carcinomas.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Sex ratio disparities in the two most common cancers worldwide: an exploratory analysis using GLOBOCAN 2022 data, gender inequalities, and economic indicators.

EClinicalMedicine·2026
Same author

More than two-thirds of patients with prostate cancer have the same or even a greater survival than the general male population: A French population-based study from Francim network of cancer registries.

The French journal of urology·2025
Same author

Influence of sex on the incidence of colorectal cancer: considering the influence of gender mechanisms.

Social science & medicine (1982)·2025
Same author

Surgical patterns of care of pancreatic cancer. A French population-based study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2024

Related Experiment Video

Updated: Jun 25, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

[Prostate cancer: update on screening].

Pascale Grosclaude1

  • 1Registre des cancers du Tarn, BP 37, Albi 81001 cedex. grosclau@cict.fr

Bulletin De L'Academie Nationale De Medecine
|February 26, 2009
PubMed
Summary

Prostate cancer screening using prostate-specific antigen (PSA) tests is common but controversial. Current evidence does not support organized screening programs improving survival, and test limitations pose risks.

Area of Science:

  • Oncology
  • Urology
  • Public Health

Context:

  • Prostate cancer is the most common male cancer in Europe.
  • Prostate-specific antigen (PSA) testing is widely used for individual screening.
  • The efficacy of mass screening for prostate cancer remains debated.

Purpose:

  • To evaluate the current evidence on prostate cancer screening.
  • To discuss the implications of widespread PSA testing.
  • To highlight the limitations of current screening tests.

Summary:

  • Organized prostate cancer screening programs lack evidence of improved survival.
  • Frequent PSA testing contributes to an apparent increase in prostate cancer incidence.
  • Screening tests have suboptimal sensitivity and specificity for aggressive tumors.

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Related Experiment Videos

Last Updated: Jun 25, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

  • Treatment side effects can be disproportionately severe for less aggressive prostate cancers.

    • Impact:

    • Clarification is needed regarding the net benefit of PSA screening.
    • Ongoing clinical trials aim to resolve the controversy surrounding PSA testing.
    • Informed decision-making for individual screening requires understanding test limitations and treatment risks.